These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26776145)

  • 1. Evaluation of the antibiotic resistance of Pseudomonas aeruginosa isolates according to the changing guidelines.
    Yanik K; Tanriverdi Cayci Y; Karadag A; Esen S; Gunaydin M
    Indian J Med Microbiol; 2016; 34(1):123-4. PubMed ID: 26776145
    [No Abstract]   [Full Text] [Related]  

  • 2. Criteria of time and antibiotic susceptibility in the elimination of duplicates when calculating resistance frequencies.
    Rodríguez JC; Sirvent E; López-Lozano JM; Royo G
    J Antimicrob Chemother; 2003 Jul; 52(1):132-4. PubMed ID: 12805258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Standardization of methods of determining microbial sensitivity to antibiotics].
    Chaĭkovskaia SM; Givental' NI; Rezvan SP
    Lab Delo; 1984; (5):299-302. PubMed ID: 6204116
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pseudomonas aeruginosa and Escherichia coli: reliability of antibiotic resistance results obtained by manual tests and automated and semi-automated equipment].
    Moretti MV; Bianchi P; Grossholz G; Moretti A; Pasticci MB; Frongillo RF
    Nuovi Ann Ig Microbiol; 1985; 36(6):453-64. PubMed ID: 3939640
    [No Abstract]   [Full Text] [Related]  

  • 5. Performance evaluation of the BD phoenix automated microbiology system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates.
    Bayramoglu G; Acuner IC; Sinirtas M; Gedikoglu S; Durupinar B
    Saudi Med J; 2006 Dec; 27(12):1921-3. PubMed ID: 17143380
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective evaluation of imipenem/EDTA combined disc and Etest for detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Bergès L; Rodriguez-Villalobos H; Deplano A; Struelens MJ
    J Antimicrob Chemother; 2007 Apr; 59(4):812-3. PubMed ID: 17317694
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of resistance to fluoroquinolones in clinical and environmental isolates of Pseudomonas aeruginosa.
    Prasad SV; Ballal M; Shivananda PG
    Indian J Pathol Microbiol; 2007 Jan; 50(1):94-6. PubMed ID: 17474274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Pseudomonas aeruginosa isolates from burn patients in the Northwest of Pakistan.
    Arya SC; Agarwal N; Agarwal S
    Burns; 2010 Aug; 36(5):739-40. PubMed ID: 20071094
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of azithromycin as an antipseudomonal agent.
    Mahapatra A; Mahapatra A; Padhi S; Mahapatro S; Ghosh SK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):634-5. PubMed ID: 17183885
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4.
    Supp DM; Gardner J; Klingenberg JM; Neely AN
    Burns; 2009 Nov; 35(7):949-55. PubMed ID: 19501982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of applying the new Clinical and Laboratory Standards Institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong.
    Ho PL; Chow KH; Tse H; Cheng VC
    Int J Antimicrob Agents; 2012 Sep; 40(3):280-1. PubMed ID: 22795656
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in the rates of antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa between 2002 and 2004 in a tertiary-care teaching hospital in Turkey.
    Işeri L; Bayraktar MR
    New Microbiol; 2008 Jul; 31(3):351-5. PubMed ID: 18843889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of antibiotic resistance patterns of Pseudomonas aeruginosa and Acinetobacter spp. strains isolated from intensive care patients between 2000-2002 and 2003-2006 periods in Dokuz Eylul University Hospital, Izmir].
    Yüce A; Yapar N; Eren Kutsoylu O
    Mikrobiyol Bul; 2009 Apr; 43(2):195-202. PubMed ID: 19621603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms.
    Bosso JA; Mauldin PD; Steed LL
    Ann Pharmacother; 2006 Nov; 40(11):1946-9. PubMed ID: 17018687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic in vitro and in vivo activities of ampicillin and aminoglycoside combinations against antibiotic-resistant Pseudomonas aeruginosa strains.
    Elkhouly AE; el-Sokkary MA; el-Emam MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):125-8. PubMed ID: 3151331
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of Pseudomonas aeruginosa sensitivity to antibiotics and features of interpreting the results].
    Givental' NI
    Antibiot Med Biotekhnol; 1987 Sep; 32(9):674-83. PubMed ID: 3124726
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergence of plasmid-mediated quinolone resistance genes in clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa in Henan, China.
    Jiang X; Yu T; Jiang X; Zhang W; Zhang L; Ma J
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):381-3. PubMed ID: 24805186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
    Macdonald D; Cuthbertson L; Doherty C; Campana S; Ravenni N; Taccetti G; Govan JR
    J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint.
    Tam VH; Gamez EA; Weston JS; Gerard LN; Larocco MT; Caeiro JP; Gentry LO; Garey KW
    Clin Infect Dis; 2008 Mar; 46(6):862-7. PubMed ID: 18279040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.